Thus, the use ACSs inhibitors may be particularly relevant in cases of cancer cells that normally rely on de novo fatty acid synthesis, but in a hypoxic tumor environment, where the oxygen-dependent SCD1 is impaired, cells are forced to switch to extracellular fatty acid uptake for survival [15,21]. Here, SCD is linked to cancer.